Planned trial of ganetespib + pemetrexed + cisplatin in mesothelioma

Trial Profile

Planned trial of ganetespib + pemetrexed + cisplatin in mesothelioma

Not stated
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 06 Aug 2013

At a glance

  • Drugs Ganetespib (Primary) ; Cisplatin; Pemetrexed
  • Indications Mesothelioma
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Aug 2013 Initiation of this trial is expected later in 2013 or early in 2014, according to a Synta Pharmaceuticals media release.
    • 06 Aug 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top